Company profile: Predictive Oncology
1.1 - Company Overview
Company description
- Provider of AI-driven oncology solutions for pharmaceutical, diagnostic, and biotech industries, including the PEDAL platform for drug-response prediction using a large tumor biobank; 3D tumor models for clinically relevant therapeutic testing; live-tumor drug-response and genomic biomarker testing; formulation services (solubility, stability, optimization) via high-throughput tech; and biologics development, purification, endotoxin detection/removal, and GMP manufacturing.
Products and services
- PEDAL Platform: An AI-driven platform leveraging a large biobank of tumor samples to produce drug-response predictions, accelerating drug discovery and development workflows for oncology programs
- Tumor Drug-Response & Genomic Biomarker Testing: Live-cell testing using patient tumor cells to identify effective cancer treatments and deliver comprehensive genomic biomarker-based reports for clinicians guiding personalized therapy decisions
- 3D Tumor Models: In vitro models that mimic the human organ microenvironment, supplying a clinically relevant platform to evaluate cancer therapeutics and predict performance in physiologically representative conditions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Predictive Oncology
Vesalius Therapeutics
HQ: United States
Website
- Description: Provider of the ContinuumDiscovery platform, which identifies clinical patterns in patient groups, links these patterns to gene circuits, and screens drug candidates to restore circuits to healthy functioning; focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vesalius Therapeutics company profile →
Sciwheel
HQ: United Kingdom
Website
- Description: Provider of customizable, intuitive, and accessible tools to advance research and discovery, enabling research and data to be published fast, openly, and cost-effectively to accelerate use, reuse, and potential impact.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sciwheel company profile →
EmpiraMed
HQ: United States
Website
- Description: Provider of registry patient-engagement software to generate real-world evidence for the life science industry, delivering a decentralized clinical study solution with automated study execution, novel patient recruitment, and mobile device independence. Products include PRO, PMR, and MED Portals, Decentralized Study Platform, Patient Incentive System, and Data Verification Model.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EmpiraMed company profile →
Seismic Therapeutic
HQ: United States
Website
- Description: Provider of machine-learning technology for immunology drug development, offering the IMPACT platform to accelerate novel biologics by integrating machine learning with structural biology, protein engineering, and translational immunology; Ig Sculpting Enzymes to modify pathogenic antibodies in autoimmune diseases, optimized for reduced immunogenicity while retaining enzyme activity; and Dual-cell Bidirectional antibodies engaging multiple inhibitory pathways in immune cells to restore immune homeostasis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seismic Therapeutic company profile →
X-Chem
HQ: United States
Website
- Description: Provider of AI-driven small molecule drug discovery solutions, including ArtemisAI to analyze DEL data and predict new binders; DEL screening services across target classes; medicinal chemistry to convert hits into leads; integrated Dynamic Drug Discovery (XD3); HITMiner to expand binder predictions; and LEADChaser to advance DEL outputs through rapid design-test loops.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full X-Chem company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Predictive Oncology
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Predictive Oncology
2.2 - Growth funds investing in similar companies to Predictive Oncology
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Predictive Oncology
4.2 - Public trading comparable groups for Predictive Oncology
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →